BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sanna V, Satta S, Hsiai T, Sechi M. Development of targeted nanoparticles loaded with antiviral drugs for SARS-CoV-2 inhibition. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Phuna ZX, Panda BP, Hawala Shivashekaregowda NK, Madhavan P. Nanoprotection from SARS-COV-2: would nanotechnology help in Personal Protection Equipment (PPE) to control the transmission of COVID-19? International Journal of Environmental Health Research. [DOI: 10.1080/09603123.2022.2046710] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Galdopórpora JM, Martinena C, Bernabeu E, Riedel J, Palmas L, Castangia I, Manca ML, Garcés M, Lázaro-martinez J, Salgueiro MJ, Evelson P, Tateosian NL, Chiappetta DA, Moretton MA. Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy. Pharmaceutics 2022;14:959. [DOI: 10.3390/pharmaceutics14050959] [Reference Citation Analysis]
3 Moreno-Mendieta S, Guillén D, Vasquez-Martínez N, Hernández-Pando R, Sánchez S, Rodríguez-Sanoja R. Understanding the Phagocytosis of Particles: the Key for Rational Design of Vaccines and Therapeutics. Pharm Res 2022. [PMID: 35739369 DOI: 10.1007/s11095-022-03301-2] [Reference Citation Analysis]
4 Lawal B, Kuo YC, Rachmawati Sumitra M, Wu ATH, Huang HS. Identification of a novel immune-inflammatory signature of COVID-19 infections, and evaluation of pharmacokinetics and therapeutic potential of RXn-02, a novel small-molecule derivative of quinolone. Comput Biol Med 2022;148:105814. [PMID: 35841781 DOI: 10.1016/j.compbiomed.2022.105814] [Reference Citation Analysis]